NCT06146842View on ClinicalTrials.gov

ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine Hydrochloride

Each subject will receive allocated dose of bupivacaine

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER